Trial reportEuropean geriatric medicine2025
Effects of 12-week exercise on Meteorin-like levels, inflammation, and functional capacity in older adults: Korean national aging project randomized controlled study.
Trial report in European geriatric medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Exercise-induced myokines in metabolic regulation: mechanisms, mimetics, and translational potential.Archives of pharmacal research · 2026Review
- Thermogenic adipose tissue in older adults with obesity: a narrative review of mechanisms, brown fat resistance, and the translational relevance of exercise and nutrition.Frontiers in nutrition · 2026Review
- Emerging Therapeutic and Inflammation Biomarkers: The Role of Meteorin-Like (Metrnl) and Follistatin-Like 1 (FSTL1) in Inflammatory Diseases.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
purposeMeteorin-like protein (Metrnl) is involved in regulating inflammation, metabolism, and muscle regeneration, making it a promising therapeutic target. Building on prior research, we investigated how exercise-induced changes in Metrnl relate to inflammatory markers, physical function, and cognitive performance. This randomized controlled trial examined the effects of a 12-week exercise intervention on circulating Metrnl, a novel biomarker, in 90 community-dwelling older adults (≥ 65 years).
methodsParticipants were randomized into a walking group (WG), a combined resistance and walking group (RWG), or an active control group (CG). Intervention groups engaged in moderate-intensity exercise; walking based on age-specific step goals and resistance training twice weekly. Blood samples and assessments of physical and cognitive function were collected pre- and post-intervention.
results79 participants successfully completed the study. After 12 weeks, serum Metrnl levels significantly increased in both RWG and WG compared to CG (WG vs. CG: p = .002; RWG vs. CG: p = .004). Metrnl changes were correlated with improvements in inflammatory markers (IL-6, p = .048; TNF-α, p = .040), physical activity (p = .041), and physical function (Timed Up & Go, p = .004; Five Times Sit to Stand Test, p = .008). Stronger associations were observed in the RWG, including cognitive gains (Stroop test, p = .040), enhanced handgrip strength (p = .036), and reduced fat mass (pp= .021). Timed Up & Go and Five Times Sit to Stand Test were the strongest predictors of Metrnl changes.
conclusionThese findings highlight Metrnl's potential as a biomarker linking exercise to reduced inflammation and improved physical and cognitive outcomes in older adults, supporting its relevance in developing targeted exercise-based therapies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.